Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 3/20 | 0.39 |
| ▸ | CCNB1 | P14635 | 3/20 | 0.39 |
| ▸ | CCNE1 | P24864 | 3/20 | 0.39 |
| ▸ | CDK2 | P24941 | 3/20 | 0.39 |
| ▸ | CDK4 | P11802 | 1/20 | 0.39 |
| ▸ | CCND1 | P24385 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | GABRP | O00591 | 1/20 | 0.37 |
| ▸ | GABRD | O14764 | 1/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.37 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.37 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.37 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.37 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.37 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.37 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.37 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.37 |
| ▸ | GABRE | P78334 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9925464 | 0.78 | TNK2 (0.49) | MEN1KMT2ACA1CA2CYP1B1 | |
| SCHEMBL11663639 | 0.78 | CA1 (0.49) | MEN1KMT2AGABRPGABRDGABRA1 | |
| SCHEMBL11546467 | 0.77 | MEN1 (0.42) | MEN1KMT2ACA1CA2CYP3A4 | |
| SCHEMBL10038095 | 0.75 | KDM4E (0.49) | KMT2ACYP1A2CYP1A1CYP1B1KDM4E | |
| SCHEMBL10038193 | 0.75 | NFKB1 (0.57) | KMT2ACYP1A2CYP1A1CYP1B1CYP2C9 | |
| SCHEMBL19683687 | 0.73 | CYP1A1 (0.40) | CDK1CCNB1CA1CA2CYP1A2 | |
| SCHEMBL11435737 | 0.73 | MEN1 (0.33) | CDK1CCNB1CCNE1CDK2CDK4 | |
| SCHEMBL11547910 | 0.73 | L3MBTL1 (0.53) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| SCHEMBL11544822 | 0.73 | MAOB (0.42) | MEN1KMT2ACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL11624054 | 0.72 | FABP4 (0.47) | CA1KDM4EMAPTTDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250304595-A1 | Electroactive Compounds | LG CHEM, LTD. (KR) | 2025-10-02 | — | — | US | disclosed |
| US-12384796-B2 | Electroactive compounds | LG CHEM, LTD. (KR) | 2025-08-12 | — | — | US | disclosed |
| CN-109153684-B | Electroactive compounds | 株式会社LG化学 | 2021-12-21 | — | — | CN | disclosed |
| WO-2017210072-A1 | ELECTROACTIVE COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2017-12-07 | — | — | WO | disclosed |
| WO-2017210072-A1 | ELECTROACTIVE COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2017-12-07 | — | — | WO | disclosed |
| US-8247810-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-08-21 | — | — | US | disclosed |
| US-8247810-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-08-21 | — | — | US | disclosed |
| US-8216753-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-07-10 | — | — | US | disclosed |
| US-8216753-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-07-10 | — | — | US | disclosed |
| US-20120146013-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-06-14 | — | — | US | disclosed |
| US-20120146013-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-06-14 | — | — | US | disclosed |
| US-20090159877-A1 | ELECTROACTIVE MATERIALS | E. I. DU PONT DE NEMOURS AND COMPANY | 2009-06-25 | — | — | US | disclosed |
| US-20090159877-A1 | ELECTROACTIVE MATERIALS | E. I. DU PONT DE NEMOURS AND COMPANY | 2009-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250304595-A1 | Electroactive Compounds | NAT1, NES, SULT1E1 | CDK1 2679/4885CCNB1 2054/4885CCNE1 291/4885 |
| US-12384796-B2 | Electroactive compounds | NES, NAT1, SCN1B | CDK1 2596/4885CCNB1 1859/4885CCNE1 285/4885 |
| US-20120146013-A1 | ELECTROACTIVE MATERIALS | RCOR3, KCNN4, MSRB3 | CDK1 2216/4885CCNB1 2638/4885CCNE1 1583/4885 |
| US-20090159877-A1 | ELECTROACTIVE MATERIALS | RCOR3, KCNN4, MSRB3 | CDK1 2216/4885CCNB1 2638/4885CCNE1 1583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.